Belardelli, Filippo
Consiglio Nazionale delle Ricerche,
Italy
2025 Rank: 38913
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1182 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38913 | 37876 |
| Total Cites | 14269 | 16499 |
| H-index | 57 | 64 |
| Hm-index | 21 | 23 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 378 | 406 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 1381 | 1585 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 5461 | 6251 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11610 | 12428 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.33 |
| Self-Citation Percentage |
13.52%
|
|
Belardelli, Filippo
Consiglio Nazionale delle Ricerche,
Italy
2024 Rank: 37241
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1149 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 37241 | 36469 |
| Total Cites | 13608 | 15799 |
| H-index | 57 | 62 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 368 | 396 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 1349 | 1553 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 5235 | 6022 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11047 | 11841 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.33 |
| Self-Citation Percentage |
13.87%
|
|
Belardelli, Filippo
CNR - Istituto di Farmacologia Traslazionale,
Italy
2023 Rank: 35440
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1125 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35440 | 34577 |
| Total Cites | 12942 | 15091 |
| H-index | 56 | 60 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 358 | 386 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 1323 | 1527 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 4973 | 5757 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10473 | 11239 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.34 |
| Self-Citation Percentage |
14.24%
|
|
Belardelli, Filippo
CNR - Istituto di Farmacologia Traslazionale,
Italy
2022 Rank: 34007
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1123 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 34007 | 33604 |
| Total Cites | 11673 | 13644 |
| H-index | 54 | 58 |
| Hm-index | 20 | 22 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 347 | 375 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 1285 | 1485 |
| Number of Single+First+Last Authored Papers | 119 | 119 |
| Total Cites to Single+First+Last Authored Papers | 4667 | 5428 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9386 | 10056 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.36 |
| Self-Citation Percentage |
14.45%
|
|
Belardelli, Filippo
CNR - Istituto di Farmacologia Traslazionale,
Italy
2021 Rank: 32294
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1078 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32294 | 31597 |
| Total Cites | 11748 | 13787 |
| H-index | 53 | 58 |
| Hm-index | 20 | 21 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 346 | 374 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 1268 | 1468 |
| Number of Single+First+Last Authored Papers | 117 | 117 |
| Total Cites to Single+First+Last Authored Papers | 4534 | 5285 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9417 | 10145 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.36 |
| Self-Citation Percentage |
14.79%
|
|
Belardelli, Filippo
CNR - Istituto di Farmacologia Traslazionale,
Italy
2020 Rank: 30288
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1032 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 30288 | 29139 |
| Total Cites | 10955 | 12962 |
| H-index | 51 | 56 |
| Hm-index | 20 | 21 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 339 | 367 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 1229 | 1429 |
| Number of Single+First+Last Authored Papers | 121 | 121 |
| Total Cites to Single+First+Last Authored Papers | 4256 | 5014 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8738 | 9416 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.38 |
| Self-Citation Percentage |
15.48%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.